Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $89.4700 (-0.98%) ($88.8600 - $92.8700) on Thu. Feb. 18, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.74% (three month average) | RSI | 37 | Latest Price | $89.4700(-0.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.3% a day on average for past five trading days. | Weekly Trend | LGND declines -6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(52%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.37% in a week (0% probabilities). VIXM(-16%) TLT(-16%) UUP(-7%) GDXJ(-5%) IPO(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.37% (StdDev 2.74%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
1 - 5 Day Possible Target | $77.61(-13.26%) | Resistance Level | $94.83 | 5 Day Moving Average | $88.13(1.52%) | 10 Day Moving Average | $89.75(-0.31%) | 20 Day Moving Average | $94.83(-5.65%) | To recent high | -20% | To recent low | 4.3% | Market Cap | $1.438b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |